This is a new LARGER size bottle (60 capsules) of Coenzyme Q that is less expensive than the smaller size we used to carry. The previous size product used to cost $1.88 per capsule, but our new price in the larger size bottle costs just $1.72 each – that’s $0.16 less per capsule of the same great product.
Coenzyme Q10 is a naturally occurring vitamin-like substance and anti-oxidant stored throughout the body in all cell membranes. DCI uses the more biologically available form of Coenzyme Q10 known as Ubiquinol as the preferred type to use in all PDI treatment plans.
Coenzyme Q10 for treatment of Dupuytren’s contracture has gained popularity since medical urologist and Peyronie’s author and expert Lawrence Levin MD has written he recommends it since the positive research results reported by Safarinejad.
DCI long ago observed that the natural treatment of Peyronie’s disease is often also beneficial to Dupuytren’s contracture when both conditions co-exist at the time of PD treatment. Clinical experience shows that many men who have both PD and DC will observe an improvement In their DC when attempting to improve their PD – and often the DC improvement is greater than the PD improvement.
Safarinejad wrote an important research paper in 2010, “Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized study. “ In this study on the safety and efficacy of coenzyme Q10 as a treatment option for PD, 184 participants were randomly assigned to take coenzyme Q10, 300 mg, daily or a similar dosage of a placebo for 24 weeks. In addition to evaluation of plaque size, these men were subjected to ongoing evaluation every four weeks as well as at the conclusion of this study if the effects of treatment were having a positive impact on their erection quality. After 24 weeks scar size and erection quality improved significantly for men receiving coenzyme Q10. No additional studies of Coenzyme Q-10 are known to be currently underway to confirm or deny the conclusions of this study.
As a person ages, the ability to store, convert and absorb CoQ10 is reduced. Since DC tends to appear with greater frequency and intensity in the older population, this suggests a possible correlation.
DCI has selected the ubiquinol form of coenzyme Q10 to use for Dupuytren’s contracture because it is more easily absorbed than the ubiquinone form. This difference makes it easier to get coenzyme Q10 into the bloodstream working to help break down the fibrous nodule and cords of DC. Any discussion about coenzyme Q10 having an adverse effect on collagenase refers to the effect of topical coenzyme Q10, not when taken internally as DCI suggests; oral coenzyme Q10 is not known to reduce collagenase activity.